Antibodies Block Migraine in Early Trials MedPage Today Both men were reporting on trials of different antibodies to a substance thought to play a central role in migraine -- calcitonin gene-related peptide, or CGRP. And results of the trials -- both small, randomized, double-blind, and placebo-controlled ... |
